Bortezomib CAS: 179324-69-7

Post Date:
Sep 23,2016
Expiry Date:
Mar 22,2017
Detailed Description:
Cas No. :179324-69-7 Quantity: 0.01Kilograms
Price:1.5 USD Metric Tons
Bortezomib CAS: 179324-69-7
Product Details:
E:steroidcn at ycgmp.com
Sky:live:bella881030
Name: Bortezomib
Synonyms: boronic:acid; Velcade; DPBA
Molecular Formula: C19H25BN4O4
Molecular Weight :384.24
CAS:179324-69-7
Loss on drying: ≤0.5% 0.1%
Burned ash: ≤0.1% 0.08%
Heavy Metals: ≤20ppm Complies
Assay :99.1%
Color: white powder
Usage: Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
CAS Registry Number:
179324-69-7
Synonyms:
;VELCADE;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide;N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide;Bortizomib;
Molecular Formula:
C₁₉H₂₅BN₄O₄
Molecular Weight:
384.2372
Molecular Structure:

Offter to Sell